Law360 reported on a Federal Circuit ruling upholding the invalidation of four pharmaceutical patents in a Hatch-Waxman litigation. Robert Florence and Chris Thomas – attorneys in Parker Poe’s Life Sciences Industry Team – represented Parker Poe’s client and worked with other defendants’ counsel to successfully obtain this win. It paves the way for their clients to bring a generic version of a branded pharmaceutical drug for the treatment of multiple sclerosis patients onto the market.
Subscribers can read the full article here. Law360 has more than 1 million newsletter recipients each day and is among the most trusted sources in the legal industry.